Gyeonggi-do, South Korea

Eun Ji Kang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eun Ji Kang: Innovator in Bicyclic Compounds

Introduction

Eun Ji Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of bicyclic compounds. With a total of 4 patents to his name, his work focuses on innovative solutions for health-related challenges.

Latest Patents

Eun Ji Kang's latest patents include two significant inventions related to bicyclic compounds. The first patent describes a 6-6 bicyclic ring-containing compound derivative that acts as a PRMT5 inhibitor. This compound has potential applications in the prevention or treatment of diseases caused by PRMT5. The second patent involves a compound derivative containing a 6-7 bicyclic ring, which also functions as a PRMT5 inhibitor, offering similar therapeutic benefits.

Career Highlights

Throughout his career, Eun Ji Kang has worked with prominent organizations such as SK Biopharmaceuticals Co., Ltd. and Konkuk University Industrial Cooperation Corporation. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Eun Ji Kang has collaborated with several professionals in his field, including Jin Hee Kim and Jun Youb Lee. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Eun Ji Kang's work in the field of bicyclic compounds showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his role as a key contributor to the development of effective treatments for diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…